ENTITY

Medicines Company (MDCO US)

Health CareUnited States
The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.
more
Exchange Announcement15 Feb 2020 00:56
Exchange Announcement12 Feb 2020 15:49
Exchange Announcement12 Feb 2020 15:23
Exchange Announcement10 Feb 2020 15:32
Exchange Announcement28 Jan 2020 17:58
x